›› 2019, Vol. 39 ›› Issue (8): 919-.doi: 10.3969/j.issn.1674-8115.2019.08.019

• Review • Previous Articles     Next Articles

Progress in augmentation therapy mechanism of obsessive compulsive disorder

REN Yan-yan, WANG Zhen   

  1. Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
  • Online:2019-08-28 Published:2019-09-23
  • Supported by:
    National Natural Science Foundation of China, 81671340; Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Support, 20161321

Abstract: Administration of selective serotonin reuptake inhibitors (SSRI) is a widely used pharmacotherapeutic approach for obsessive-compulsive disorder (OCD) today. However, nearly half of the OCD patients do not respond to SSRI. It has been shown that some antipsychotic drugs can augment the therapeutic effect of SSRI in the patients with OCD, but the augmentation’s effect is still ineffective for some patients.Therefore, it is of great significance to explore the augmentation’s mechanism for further improvement of the clinical treatment. This article reviews some common used augmentation for OCD and discusses the underlying mechanisms.

Key words: obsessive compulsive disorder (OCD), augmentation, selective serotonin reuptake inhibitor (SSRI), antipsychotics

CLC Number: